The BsepE297G model presented herein demonstrates a clinically relevant PFIC2 phenotype including cholestasis, as demonstrated by decreased biliary-BA and increased hepatic and serum-BA content, and elevated markers of liver injury, including ALT, ALP, and hepatomegaly. This evidence concerns the gene ABCB11 and cholestasis.